GLASSIA (Baxalta USA Inc.)


Welcome to the PulseAid listing for the GLASSIA drug offered from Baxalta USA Inc.. This Human alpha-1 Proteinase Inhibitor [EPC],Trypsin Inhibitors [MoA] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.

LABELER NAME / MANUFACTURER: Baxalta USA Inc.
NON-PROPRIETARY NAME: .ALPHA.1-PROTEINASE INHIBITOR HUMAN
SUBSTANCE NAME: .ALPHA.1-PROTEINASE INHIBITOR HUMAN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human alpha-1 Proteinase Inhibitor [EPC],Trypsin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2010-07-01
END MARKETING DATE: 0000-00-00


GLASSIA PLASMA DERIVATIVE Details:

Item DescriptionGLASSIA from Baxalta USA Inc.
LABELER NAME: Baxalta USA Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(g/50mL)
START MARKETING DATE: 2010-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0944-2884_f4f45338-0292-4ce0-877d-8bdb7d4b1e38
PRODUCT NDC: 0944-2884
APPLICATION NUMBER: BLA125325

Other .ALPHA.1-PROTEINASE INHIBITOR HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxalta USA Inc.GLASSIA